CardioPharmaGENET Stakeholder Newsletter
CardioPharmaGENET is pleased to share its first Stakeholder Newsletter, highlighting key milestones, activities and achievements from the Action’s first year.
The newsletter provides an overview of the work carried out across the Action’s five Working Groups, with particular attention to research collaboration, capacity building, networking, policy engagement, knowledge exchange and scientific dissemination.
Engagement with stakeholders is central to the development and long-term impact of CardioPharmaGENET. The newsletter highlights opportunities to connect with the Action’s activities and contribute to the growing European network in cardiovascular pharmacogenomics and precision medicine.
📖 Read the Stakeholder Newsletter and discover the latest CardioPharmaGENET activities